{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:49:53Z","timestamp":1794048593318,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":747,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cell.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T09:34:10Z","timestamp":1309167250000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1327,"title":["Gaucher Disease Glucocerebrosidase and \u03b1-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies"],"prefix":"10.1016","volume":"146","author":[{"given":"Joseph\u00a0R.","family":"Mazzulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam\u00a0L.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela\u00a0J.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy\u00a0A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory\u00a0A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2011.06.001_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.06.001_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9258(18)97611-8","article-title":"The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue","volume":"240","author":"Brady","year":"1965","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.06.001_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cell.2011.06.001_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration","volume":"123","author":"Chandra","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cell.2011.06.001_bib5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in\u00a0vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2011.06.001_bib6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.06.001_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ana.10279","article-title":"Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases","volume":"52","author":"Duda","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2011.06.001_bib8","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1016\/S0021-9258(17)38720-3","article-title":"Biosynthesis of the lysosomal enzyme glucocerebrosidase","volume":"260","author":"Erickson","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.06.001_bib9","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.06.001_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2011.06.001_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cell.2011.06.001_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2011.06.001_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2011.06.001_bib14","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.06.001_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cell.2011.06.001_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1073\/pnas.61.2.484","article-title":"The fine structure of the cerebroside occurring in Gaucher's disease","volume":"61","author":"Lee","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2011.06.001_bib17","unstructured":"Lill, C.M., Roehr, J.T., McQueen, M.B., Bagade, S., Kavvoura, F., Schjeide, B.M.M., Allen, N.C., Tanzi, R., Khoury, M.J., Ioannidis, J.P.A., and Bertram, L. (2008). The PDGene Database. Alzheimer Research Forum. Available at: http:\/\/www.pdgene.org Accessed 09\/2008-03\/2009."},{"key":"10.1016\/j.cell.2011.06.001_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cell.2011.06.001_bib19","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cell.2011.06.001_bib20","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","article-title":"GM1 specifically interacts with alpha-synuclein and inhibits fibrillation","volume":"46","author":"Martinez","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.cell.2011.06.001_bib21","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1523\/JNEUROSCI.0896-06.2006","article-title":"Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates","volume":"26","author":"Mazzulli","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cell.2011.06.001_bib22","doi-asserted-by":"crossref","first-page":"31621","DOI":"10.1074\/jbc.M704737200","article-title":"Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence","volume":"282","author":"Mazzulli","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2011.06.001_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.cell.2011.06.001_bib24","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.cell.2011.06.001_bib25","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","article-title":"Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells","volume":"31","author":"Seibler","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cell.2011.06.001_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymgme.2004.11.007","article-title":"Gaucher disease and parkinsonism","volume":"84","author":"Sidransky","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cell.2011.06.001_bib27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2011.06.001_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-2836(65)80111-5","article-title":"The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites","volume":"13","author":"Stryer","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cell.2011.06.001_bib29","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cell.2011.06.001_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cell.2011.06.001_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cell.2011.06.001_bib32","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.e09-09-0801","article-title":"Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs","volume":"21","author":"Thayanidhi","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cell.2011.06.001_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0161-813X(02)00065-7","article-title":"Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses","volume":"23","author":"Trojanowski","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cell.2011.06.001_bib34","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.4977-09.2010","article-title":"Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration","volume":"30","author":"Tsika","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cell.2011.06.001_bib35","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.cell.2011.06.001_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cell.2011.06.001_bib37","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2011.06.001_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cell.2011.06.001_bib39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cell.2011.06.001_bib40","doi-asserted-by":"crossref","unstructured":"Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71\u201394.","DOI":"10.1093\/genetics\/77.1.71"},{"key":"10.1016\/j.cell.2011.06.001_bib41","doi-asserted-by":"crossref","unstructured":"Deglon, N., Tseng, J.L., Bensadoun, J.C., Zurn, A.D., Arsenijevic, Y., Pereira de Almeida, L., Zufferey, R., Trono, D., and Aebischer, P. (2000). Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11, 179\u2013190.","DOI":"10.1089\/10430340050016256"},{"key":"10.1016\/j.cell.2011.06.001_bib42","doi-asserted-by":"crossref","unstructured":"Hamamichi, S., Rivas, R.N., Knight, A.L., Cao, S., Caldwell, K.A., and Caldwell, G.A. (2008). Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. USA 105, 728\u2013733.","DOI":"10.1073\/pnas.0711018105"},{"key":"10.1016\/j.cell.2011.06.001_bib43","doi-asserted-by":"crossref","unstructured":"Kaushik, S., and Cuervo, A.M. (2009). Methods to monitor chaperone-mediated autophagy. Methods Enzymol. 452, 297\u2013324.","DOI":"10.1016\/S0076-6879(08)03619-7"},{"key":"10.1016\/j.cell.2011.06.001_bib44","doi-asserted-by":"crossref","unstructured":"Marshall, J., McEachern, K.A., Kyros, J.A., Nietupski, J.B., Budzinski, T., Ziegler, R.J., Yew, N.S., Sullivan, J., Scaria, A., van Rooijen, N., et\u00a0al. (2002). Demonstration of feasibility of in\u00a0vivo gene therapy for Gaucher disease using a chemically induced mouse model. Mol. Ther. 6, 179\u2013189.","DOI":"10.1006\/mthe.2002.0650"},{"key":"10.1016\/j.cell.2011.06.001_bib45","doi-asserted-by":"crossref","unstructured":"Mazzulli, J.R., Mishizen, A.J., Giasson, B.I., Lynch, D.R., Thomas, S.A., Nakashima, A., Nagatsu, T., Ota, A., and Ischiropoulos, H. (2006). Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J. Neurosci. 26, 10068\u201310078.","DOI":"10.1523\/JNEUROSCI.0896-06.2006"},{"key":"10.1016\/j.cell.2011.06.001_bib46","doi-asserted-by":"crossref","unstructured":"Mazzulli, J.R., Armakola, M., Dumoulin, M., Parastatidis, I., and Ischiropoulos, H. (2007). Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence. J. Biol. Chem. 282, 31621\u201331630.","DOI":"10.1074\/jbc.M704737200"},{"key":"10.1016\/j.cell.2011.06.001_bib47","doi-asserted-by":"crossref","unstructured":"Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C., and Krainc, D. (2011). Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 31, 5970\u20135976.","DOI":"10.1523\/JNEUROSCI.4441-10.2011"},{"key":"10.1016\/j.cell.2011.06.001_bib48","doi-asserted-by":"crossref","unstructured":"Stone, D.L., Tayebi, N., Orvisky, E., Stubblefield, B., Madike, V., and Sidransky, E. (2000). Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum. Mutat. 15, 181\u2013188.","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S"},{"key":"10.1016\/j.cell.2011.06.001_bib49","doi-asserted-by":"crossref","unstructured":"Sun, Y., Quinn, B., Witte, D.P., and Grabowski, G.A. (2005). Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants. J. Lipid Res. 46, 2102\u20132113.","DOI":"10.1194\/jlr.M500202-JLR200"},{"key":"10.1016\/j.cell.2011.06.001_bib50","doi-asserted-by":"crossref","unstructured":"Tropak, M.B., Reid, S.P., Guiral, M., Withers, S.G., and Mahuran, D. (2004). Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients. J. Biol. Chem. 279, 13478\u201313487.","DOI":"10.1074\/jbc.M308523200"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411006015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867411006015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:13:04Z","timestamp":1758798784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867411006015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0092867411006015"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2011.06.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13356043.14731080","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13356043.14726166","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher Disease Glucocerebrosidase and \u03b1-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2011.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}